European Medicines Agency recommends extending use of Abraxane to include treatment of pancreatic cancer

View source ↗

Summary

The EMA recommends extending the use of Abraxane to include treatment of pancreatic cancer, potentially expanding its approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)